Two months after the government allowed fast-track authorization of vaccines already cleared by US, UK, EU and Japan’s drug regulators or WHO, an application received from Moderna through their Indian partner Cipla has met with emergency use authorization. They say, better late than never. But the pandemic has shown that every little delay can be deadly.
Moreover, the timeline and numbers for Moderna doses are not available yet. Even more critically, negotiations are still underway on the company getting indemnity in India as it has gotten elsewhere.
Also read: DCGI gives emergency use nod to Moderna’s vaccine
The European Commission and US for example had announced various liability waiver clauses with vaccine-makers in 2020 itself.
END OF ARTICLE